Preincubation of donor bone marrow cells with a combination of murine monoclonal anti-T-cell antibodies without complement does not prevent graft-versus-host disease after allogeneic marrow transplantation

scientific article published on 01 January 1984

Preincubation of donor bone marrow cells with a combination of murine monoclonal anti-T-cell antibodies without complement does not prevent graft-versus-host disease after allogeneic marrow transplantation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/BF00915282
P953full work available at URLhttp://link.springer.com/article/10.1007/BF00915282/fulltext.html
http://link.springer.com/content/pdf/10.1007/BF00915282.pdf
http://link.springer.com/content/pdf/10.1007/BF00915282
P698PubMed publication ID6365949

P50authorE. Donnall ThomasQ310485
P2093author name stringJ. A. Hansen
P. J. Martin
P2860cites workProtection of lethally irradiated mice with allogeneic fetal liver cells: influence of irradiation dose on immunologic reconstitutionQ27820715
Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First RemissionQ28305230
Immunoadsorption for removal of A and B blood-group antibodiesQ34275461
Bone-marrow transplantation (first of two parts).Q34649003
Protection of lethally irradiated mice by spleen cells from neonatally thymectomized miceQ37450171
Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-SepharoseQ39218339
Anti-lymphocytic antibodies and marrow transplantation. 3. Effect of heterologous anti-brain antibodies on acute secondary disease in miceQ48608585
Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-versus-host disease in allogeneic histocompatible bone-marrow transplantation.Q64893104
Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environmentQ70239474
Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allograftsQ70548406
Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemiaQ72524201
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectimmunologyQ101929
P304page(s)18-22
P577publication date1984-01-01
P1433published inJournal of Clinical ImmunologyQ6294961
P1476titlePreincubation of donor bone marrow cells with a combination of murine monoclonal anti-T-cell antibodies without complement does not prevent graft-versus-host disease after allogeneic marrow transplantation
P478volume4

Reverse relations

cites work (P2860)
Q44206124A human complement-fixing monoclonal anti-human lymphocyte antibody of rat origin
Q88573546Defining success with cellular therapeutics: the current landscape for clinical end point and toxicity analysis
Q26799602Effects of T-Cell Depletion on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in AML Patients
Q38742867Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future.
Q39839309Graft-versus-host disease in dog and man: the Seattle experience
Q24296933Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen)
Q38164280Immunotherapy trials: current status and future directions with special emphasis on biologic drugs
Q52763837Role of αβ T Cell Depletion in Prevention of Graft versus Host Disease.
Q39748423The current status of monoclonal antibodies in the diagnosis and therapy of cancer
Q70366723Use of flow microfluorometry in bone marrow transplantation

Search more.